Value for money of changing healthcare services? Economic evaluation of quality improvement

Quality and Safety in Health Care

Volumn 12, Issue 5, 2003, Pages 366-371

  Severens, J L ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; GENERAL PRACTICE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HEALTH SERVICE; HUMAN; MEDICAL AUDIT; MONEY; QUALITY CONTROL; REVIEW; THROMBOSIS;

EID: 0142178108     PISSN: 09638172     EISSN: None     Source Type: Journal    
DOI: 10.1136/qhc.12.5.366     Document Type: Review

References (18)

1. Cleemput I, Kesteloot K. Economic implications of non-compliance in health care. Lancet 2002;359:2129-30.
2. Freemantle N, Harvey E, Grimshaw J, et al. The effectiveness of printed educational materials in changing the behaviour of health care professionals. In: Freemantle N, Bero L, Grilli R, et al, eds. Effective professional practice module. Cochrane Database of Systematic Reviews. Issue 3. Oxford: Update, 1996.
3. Antman E, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomzed control trials and recommendations of clinical experts. JAMA 1992;268:240-8.
4. Freemantle N, Mason JM. Is all publicity good publicity? A review of the Prozac years. PharmacoEconomics 2000;17:319-24.
5. Kaner EFS, Lock CA, McAvoy BR, et al. An RCT of three training and support strategies to encourage implementation of screening and brief alcohol intervention by general practitioners. Br J Gen Pract 1999;49: 699-703.
6. Verstappen WHJM, Merode GG van, Grimshaw GM, et al. Costs and cost reductions of a quality strategy to improve test ordering in general practice. 2003 (submitted for publication).
7. Lobo CM, Euser L, Kamp J, et al. Process evaluation of a multifaceted intervention to improve cardiovascular disease prevention in general practice. Eur J Gen Pract 2003 (in press).
8. Mason J, Freemantle N, Nazareth I, et al. When is it cost-effective to change the behaviour of health professionals? JAMA 2001;286:2988-92.
9. Winkens RAG, Ament A, Pop P. Routine individual feedback on requests for diagnostic tests: an economic evaluation. Med Decis Making 1996; 16:309-14.
10. Mauskopf JA, Paul JE, Grant DM, et al. The role of cost-consequence analysis in health care decision making. PharmacoEconomics 1998;13:277-88.
11. McIntosh E, Donaldson C, Ryan M. Recent advances in the methods of cost-benefit analysis in health care. PharmacoEconomics 1999;15: 357-67.
12. Robinson MB, Thompson E, Black NA. Why is the evaluation of the cost-effectiveness of audit so difficult? The example of thrombolysis for suspected acute myocardial infarction. Qual Health Care 1998;7:19-26.
13. Schermer TR, Thoonen BP, van de Boom G, et al. Randomized controlled economic evaluation of asthma self-management in primary health care. Am J Respir Crit Care Med 2002;166:1062-72.
14. Freemantle N, Eccles M, Wood J, et al. A randomised trial of evidence-based outreach (EBOR): rationale and design. Controlled Clinical Trials 1999;20:479-92.
15. Freemantle N, Nazareth I, Eccles M, et al. A randomised trial of the effect of educational outreach by community pharmacists on prescribing in primary care. Br J Gen Pract 2002;52:290-5.
16. Sculpher M. Evaluating the cost-effectiveness of interventions designed to increase the utilization of evidence-based guidelines. Fam Pract 2000; 17(Suppl 1):S26-31.
17. Durieux P, Nizard R, Ravaud P, et al. A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA 2000;283:2816-21.
18. Watson MJ, Gunnell D, Peters TJ, et al. Guidelines and educational outreach visits from community pharmacists to improve prescribing in general practice: a randomised controlled trial. J Health Serv Res Policy 2001;6:207-13.